Page 2 - குயின்ஸ்லாந்து மூளை நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share A potential therapy developed at The University of Queensland may one day save lives by helping patients recover faster from severe trauma, extensive burns and major surgery. UniQuest, UQ’s technology transfer company, has partnered with global biotechnology company CSL to accelerate the development of a potential treatment for the repair of blood vessels damaged by inflammation. Dr Coulthard said the technology could benefit critically ill patients with sepsis or acute respiratory distress syndrome, as well as improve patient recovery from heart attack, stroke and organ transplant. “It may also prevent high-risk patients from developing Systemic Inflammatory Response Syndrome (SIRS), which affects more than half of critically ill patients and contributes to significant mortality and morbidity,” Dr Coulthard said.

Trent woodruffPerry bartlettMark coulthardNemat khanAndrew boydHead of global research innovation marthe dombrainSchool of biomedical sciencesQueensland brain instituteUniversity of queenslandResearch acceleration initiativeAssociate professor mark coulthardQueensland childrenProfessor trent woodruffBiomedical sciencesSystemic inflammatory response syndromeProfessor andrew boyd